Welcome to Clinical Leader Live – An interactive forum to discuss some of the most important technologies and trends impacting clinical trials.

Throughout the year, our Chief Editor, Ed Miseta, sits down with industry experts to discuss how sponsor companies can tackle some of today's biggest challenges they may face in managing a clinical trial. Even better, the audience gets ask questions during the presentation. Each Clinical Leader Live session is archived and can be accessed at any time by registered site users.

CLINICAL TECHNOLOGY IMPLEMENTATION

  • Overcome The Challenges Of A Clinical Technology Implementation

    New technologies can offer many benefits to a clinical operations department. Those benefits can include faster, more efficient, and less costly trials. Still, the risk averse nature of many pharma companies can make them reluctant to adopt new technologies. In November 2019, Lawrence Florin, president of LBF Biopharma Consulting, provided actionable information on how to overcome the hurdles of acquiring a new technology.

CRO BENCHMARK PRICING MODELS

  • How Do You Implement A Benchmark Pricing Model?

    In August 2019 Clinical Leader Live was proud to feature Bari Kowal, Jonathan Cohen, and Reb Tayyabkhan of Regeneron Pharmaceuticals to discuss Developing a Benchmark Pricing Model for CROs. During the presentation, the team covered several topics, including implementing the model, the effects of company size, why the sudden interest in these models, and the feedback from CROs. In this video, the three executives discuss how you go about implementing a benchmark pricing model.

RISK BASED MONITORING

  • RBM: Challenges And Opportunities

    If you’re like most clinical operations professionals from a small- to mid-sized pharma and biopharm, what you have heard about RBM has left you with more questions than answers. Jennifer Newman is the Global Project Leader for Regulatory Affairs and Clinical Operations at Celldex Therapeutics. Jennifer's experience with RBM stems from having been part of the first team to implement RBM in a large-scale study.

Ed Miseta

Ed Miseta



Ed Miseta is chief editor for the website Clinical Leader, executive editor for Life Science Leader magazine, conference chair for Clinical Leader Forum, and host of Clinical Leader Live. Ed studied Business Economics at The Pennsylvania State University and also holds a Master’s degree in Business Administration. Ed has been a writer for more than 12 years and has been covering clinical research since January 2013. Ed spent 10 years in banking and investments and also taught economics at Penn State for 8 years. In his current position, Ed interviews clinical executives from pharmaceutical and biotech companies and shares their insights with readers. His primary focus is on best practices, challenges faced and overcome, clinical trends, partnering, and implementing new technologies. He has also moderated numerous speaker panels at industry conferences and trade shows.